Literature DB >> 11293791

Drosophila telomeric transgenes provide insights on mechanisms of gene silencing.

L L Wallrath1.   

Abstract

A significant fraction of most eukaryotic genomes is packaged into chromatin that is not permissive for gene expression. This silent chromatin is typically located near centromeres and telomeres and has fascinated scientists for more than 70 years, yet many questions remain unanswered. Part of the difficulties in studying silent chromatin at the molecular level is the repetitive nature of the DNA sequences in these regions. To overcome this problem, Drosophila stocks carrying in vitro designed transgenes inserted within silent chromatin have been generated. Molecular analysis of these transgenes has shed light on the nature of the chromatin structure within these regions and provided insights on the mechanisms of gene silencing. This review will focus on recent studies using telomeric transgenes. The results from these studies suggest that nuclear organization plays a role in gene silencing and that silencing is the result of a block early in the process of transcription initiation.

Entities:  

Mesh:

Year:  2000        PMID: 11293791     DOI: 10.1023/a:1026556705137

Source DB:  PubMed          Journal:  Genetica        ISSN: 0016-6707            Impact factor:   1.082


  3 in total

1.  The promoter of the heterochromatic Drosophila telomeric retrotransposon, HeT-A, is active when moved into euchromatic locations.

Authors:  Janet A George; Mary-Lou Pardue
Journal:  Genetics       Date:  2003-02       Impact factor: 4.562

2.  Drosophila atm/telomere fusion is required for telomeric localization of HP1 and telomere position effect.

Authors:  Sarah R Oikemus; Nadine McGinnis; Joana Queiroz-Machado; Hanna Tukachinsky; Saeko Takada; Claudio E Sunkel; Michael H Brodsky
Journal:  Genes Dev       Date:  2004-07-15       Impact factor: 11.361

3.  Telomeric position effect--a third silencing mechanism in eukaryotes.

Authors:  J Greg Doheny; Randy Mottus; Thomas A Grigliatti
Journal:  PLoS One       Date:  2008-12-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.